• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy

cafead

Administrator
Staff member
  • cafead   Jun 16, 2024 at 09:12: PM
via The Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk (NOVOb.CO) CEO Lars Jorgensen has agreed to testify voluntarily in a hearing focusing on U.S. prices for weight loss drugs Ozempic and Wegovy.

article source
 

<